• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[吡喃衍生物的化学与药理学。十七。取代的2-(二烷基氨基)-3-甲酰基色酮及其三环衍生物的合成]

[Chemistry and pharmacology of pyrane derivatives. XVII. Synthesis of substituted 2-(dialkylamino)-3-formylchromones and their tricyclic derivatives].

作者信息

Balbi A, Roma G, Mazzei M, Sottofattori E, Cadel S, Schiantarelli P

机构信息

Istituto di Scienze Farmaceutiche, Università di Genova.

出版信息

Farmaco. 1989 Jun;44(6):565-77.

PMID:2803447
Abstract

Substituted 2-(dialkylamino)-3-formylchromones (II) were obtained from the reaction of substituted 2-(dialkylamino)chromones (I) either with the N,N-dimethylformamide-POCl3 reagent [compounds (IIa-e)] or with dichloromethylmethylether in the presence of TiCl4 [compounds (IIf-i)]. By treating (IIa,f) with hydroxylamine the oximes (IIIa,f) were prepared, which in turn were converted into the nitriles (IVa,f) by treatment with acetic anhydride. Compound (IIa), selected for the smallest steric hindrance of the 2-dialkylamino substituent, by reaction with hydrazines afforded [1]benzopyrano [2,3-c]pyrazole derivatives (VI), whereas reaction of (IIa) with guanidine, benzamidine or S-methylisothiourea gave rise to the formation of 5H-[1]benzopyrano[2,3-d]pyrimidine derivatives (IX). Among the compounds tested for their antiallergic properties, (IIf) showed an appreciable activity, but also high toxicity.

摘要

取代的2-(二烷基氨基)-3-甲酰基色酮(II)是由取代的2-(二烷基氨基)色酮(I)与N,N-二甲基甲酰胺-POCl₃试剂[化合物(IIa - e)]或在TiCl₄存在下与二氯甲基甲基醚反应[化合物(IIf - i)]制得的。通过用羟胺处理(IIa,f)制备了肟(IIIa,f),然后用乙酸酐处理将其转化为腈(IVa,f)。选择具有最小空间位阻的2-二烷基氨基取代基的化合物(IIa),通过与肼反应得到[1]苯并吡喃并[2,3 - c]吡唑衍生物(VI),而(IIa)与胍、苯甲脒或S-甲基异硫脲反应则生成5H-[1]苯并吡喃并[2,3 - d]嘧啶衍生物(IX)。在测试其抗过敏特性的化合物中,(IIf)表现出可观的活性,但毒性也很高。

相似文献

1
[Chemistry and pharmacology of pyrane derivatives. XVII. Synthesis of substituted 2-(dialkylamino)-3-formylchromones and their tricyclic derivatives].[吡喃衍生物的化学与药理学。十七。取代的2-(二烷基氨基)-3-甲酰基色酮及其三环衍生物的合成]
Farmaco. 1989 Jun;44(6):565-77.
2
[Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran].
Farmaco Sci. 1986 Aug;41(8):611-21.
3
[Chemistry and pharmacology of pyran derivatives. 16. Derivatives of 2-(dialkylamino)-7-methoxychromone with antiallergic activity].
Farmaco Sci. 1985 Dec;40(12):895-908.
4
[Chemical and pharmacological research on pyran derivatives. XV. Phenyl-substituted 2-(dialkylamino)chromones].[吡喃衍生物的化学与药理学研究。第十五部分。苯基取代的2-(二烷基氨基)色酮]
Farmaco Sci. 1982 Sep;37(9):582-96.
5
[1,5-benzodiazepines. V. Synthesis of pyrazolo (3,4-b)(1,5)benzodiazepines and 5H-pyrimido(4,5-b)(1,5)benzodiazepines].[1,5-苯并二氮杂卓。V. 吡唑并(3,4-b)(1,5)苯并二氮杂卓和5H-嘧啶并(4,5-b)(1,5)苯并二氮杂卓的合成]
Farmaco Sci. 1983 Aug;38(8):546-58.
6
Synthesis and pharmacological study of new N-methyl 1,2,3-triazole derivatives of 2-cyano chromones.新型2-氰基色酮的N-甲基-1,2,3-三唑衍生物的合成与药理学研究
Farmaco. 1990 Jul;45(7-8):847-57.
7
[Chemical and pharmacological research on pyran derivatives. VII. Derivatives of naphto/1',2':5,6/pyran/2,3-c/pyrazole and of 12H-naphto/1',2':5,6/pyran/2,3-d/pyrimidine].吡喃衍生物的化学与药理学研究。VII. 萘并/1',2':5,6/吡喃/2,3-c/吡唑及12H-萘并/1',2':5,6/吡喃/2,3-d/嘧啶的衍生物
Farmaco Sci. 1977 Jan;32(1):40-53.
8
[Chemical and pharmacological research on pyran derivatives. VIII. Synthesis of 2-dialkylamino-7-methoxychromones and derivatives].
Farmaco Sci. 1977 May;32(5):375-87.
9
[Chemical and pharmacologic study on pyran derivatives. IX. Synthesis of 2-dialkylaminochromones].吡喃衍生物的化学与药理学研究。IX. 2-二烷基氨基色酮的合成
Farmaco Sci. 1977 Oct;32(10):713-24.
10
[Chemical and pharmacological research on pyran derivatives. XII. Bis-(beta-chloroethyl)amino-substituted chromones and benzochromones].
Farmaco Sci. 1979 Jan;34(1):52-61.